Skip to content

Nvidia reportedly takes minority stakes in four French AI startups

·StartupReader editorial desk· 1 min readReviewed by our editors
STAKE PURCHASE. Minority stakes in four French AI startups; One startup is healthcare booking platform Doctolib; Size and value of investments not disclosed.

Reports suggest Nvidia has taken minority stakes in four French technology startups, one of which is healthcare booking platform Doctolib. The size and value of the investments were not disclosed, though Doctolib had previously indicated Nvidia’s involvement could support its AI development.

The potential deals could align with Nvidia’s recent activity in the AI startup space. Earlier this year, the company acquired Hugging Face, an open-source AI platform, and has been in discussions about increasing its stake in Reflection AI. Such moves might indicate an interest in engaging with companies building AI applications across different sectors.

Doctolib’s focus on healthcare could be relevant, given the sector’s evolving relationship with AI. If the other three startups follow similar themes, they may represent opportunities for AI integration in industries where adoption has been gradual. However, details about these companies remain unreported.

The investments, if confirmed, would come at a time when European markets are paying closer attention to large tech firms’ activities. Minority stakes, rather than full acquisitions, could offer a way to collaborate without triggering regulatory concerns. For startups, such partnerships might provide access to resources beyond capital, though the long-term implications remain uncertain.

Sources: economictimes.indiatimes.com

“Reports of Nvidia’s investments in French startups may reflect broader efforts to expand AI partnerships beyond its core hardware business.”
— StartupReader
ShareLinkedInXWhatsApp

Read the original reporting

The outlets below did the original reporting.

Related briefs

This brief was drafted automatically from the sources above and published under our editorial policy. Spotted an error? Tell us.